Evidence map›Paper›PMID 37727866›Full record

ReviewLancet regional health. Americas2023

Experiences with SARS-CoV-2 (Covid-19) in Trinidad and Tobago, a small island developing state: realities and opportunities.

Darren Dookeeram, Seetharaman Hariharan, Ian Hambleton, Kareema Ali, Surujpaul Teelucksingh, Samuel Ramsewak, Dave Dookeeram, Sandeep Bhupendra Maharaj

Abstract readReview
In one paragraph

Review in Lancet regional health. Americas, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Darren DookeeramSangre Grande Hospital, Eastern Regional Health Authority, Trinidad and Tobago.
Seetharaman HariharanSchool of Graduate Studies, The University of the West Indies, Trinidad and Tobago.
Ian HambletonGeorge Alleyne Chronic Disease Research Centre, Caribbean Institute for Health Research, The University of the West Indies, Barbados.
Kareema AliSangre Grande Hospital, Eastern Regional Health Authority, Trinidad and Tobago.
Surujpaul TeelucksinghFaculty of Medical Sciences, The University of the West Indies, Trinidad and Tobago.
Samuel RamsewakFaculty of Medical Sciences, The University of the West Indies, Trinidad and Tobago.
Dave DookeeramDispatchHealth, Denver, CO, USA.
Sandeep Bhupendra MaharajSchool of Pharmacy, The University of the West Indies, Trinidad and Tobago.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic has exerted significant global challenges that are expressed in a variety of socio-politico-economic scenarios, depending upon individual countries' preparedness and resilience. The impact COVID-19 in Small Island Developing States (SIDS), most of which are categorized as Lower and Middle-Income Countries, has been pronounced. Furthermore, many of these SIDS possess specific vulnerabilities to global threats. This paper contextualizes the experience of Trinidad and Tobago from some perspectives of geoeconomics, healthcare, and international relations. In many ways, the experience is similar to that of other SIDS with the inherent nuances of a post-colonial world. Trinidad and Tobago was ranked number one by the Oxford University COVID-19 Government Response Tracker (OxCGRT) "Lockdown rollback checklist: Do countries meet WHO recommendations for rolling back lockdown?". Despite the significant political support to combat the disease, by the end of 2022, the country had recorded over four thousand deaths and just over 50% of the population is vaccinated. This paper seeks to discuss the successes and challenges faced by this twin island state.

Indexed as

COVID 19OpportunitiesTrinidad and Tobago

Identifiers

PMID37727866
PMCPMC10505969

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.